New medicines are key to curbing high cost of dementia care

Investing in drug discovery is the only way to stop the high costs of dementia care, write Leonard A. Lauder and Howard Fillit of the Alzheimer's Drug Discovery Foundation in response to an article about an expected large increase in demand for dementia-related care. More work and resources are needed to speed the discovery of treatments, and collaborative financing models can help, they write.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief: